A detailed history of Jump Financial, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 40,182 shares of ITOS stock, worth $300,159. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,182
Previous 25,784 55.84%
Holding current value
$300,159
Previous $382,000 7.33%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $145,275 - $258,732
14,398 Added 55.84%
40,182 $410,000
Q2 2024

Aug 14, 2024

BUY
$10.33 - $18.09 $266,348 - $466,432
25,784 New
25,784 $382,000
Q4 2023

Oct 21, 2024

BUY
$8.57 - $11.06 $276,571 - $356,928
32,272 Added 125.16%
58,056 $635,000
Q4 2023

Feb 07, 2024

BUY
$8.57 - $11.06 $497,539 - $642,099
58,056 New
58,056 $635,000
Q1 2022

May 12, 2022

SELL
$31.92 - $47.45 $1.34 Million - $1.99 Million
-41,900 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$26.23 - $47.86 $1.1 Million - $2.01 Million
41,900 New
41,900 $1.95 Million
Q3 2021

Nov 12, 2021

SELL
$23.91 - $29.58 $470,022 - $581,483
-19,658 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$17.9 - $36.1 $351,878 - $709,653
19,658 New
19,658 $504,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $266M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.